{"id":225447,"date":"2026-09-01T11:24:50","date_gmt":"2026-09-01T05:54:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=225447"},"modified":"2026-09-01T11:24:50","modified_gmt":"2026-09-01T05:54:50","slug":"why-caplin-point-laboratories-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/","title":{"rendered":"Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price Rises 5.30% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories Ltd. (CAPLIPOINT)<\/a> share price rose to Rs 2,650.65 today, up 5.3% from the previous close. Market cap was Rs 19,125.3 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Caplin Point Laboratories Ltd. rose to Rs 2,650.65, up 5.30% today, with market capitalisation at Rs 19,125.30 crore.<\/p>\n<p><strong>Caplin Point Laboratories Share Price<\/strong> is at Rs 2,650.65 today, up Rs 133.40 or 5.30% from the previous close of Rs 2,517.25. The stock opened at Rs 2,532.25, hit a high of Rs 2,656.85, touched a low of Rs 2,521.40 and traded with turnover of Rs 1.83 crore. The move keeps the stock in focus within Healthcare and the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p><strong>Caplin Point Laboratories Share Price<\/strong> is drawing attention because the price gain is visible, but the supplied data does not confirm a company-specific trigger. That means today\u2019s move is best read through price action, valuation, profitability, industry benchmarks and peer comparison rather than through any unverified catalyst narrative.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Caplin_Point_Laboratories_Share_Price_Today_Price_Action_Analysis\" title=\"Caplin Point Laboratories Share Price Today: Price Action Analysis\">Caplin Point Laboratories Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Fundamental_Analysis\" title=\"Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis\">Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Why_Investors_Are_Watching_Caplin_Point_Laboratories_Ltd\" title=\"Why Investors Are Watching Caplin Point Laboratories Ltd.\">Why Investors Are Watching Caplin Point Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#About_Caplin_Point_Laboratories_Ltd\" title=\"About Caplin Point Laboratories Ltd.\">About Caplin Point Laboratories Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Track_Caplin_Point_Laboratories_Share_Price_on_Univest\" title=\"Track Caplin Point Laboratories Share Price on Univest\">Track Caplin Point Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#Why_is_Caplin_Point_Laboratories_Share_Price_rising_today\" title=\"Why is Caplin Point Laboratories Share Price rising today?\">Why is Caplin Point Laboratories Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#What_is_Caplin_Point_Laboratories_Share_Price_Today\" title=\"What is Caplin Point Laboratories Share Price Today?\">What is Caplin Point Laboratories Share Price Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#How_does_the_company_compare_on_valuation_and_profitability\" title=\"How does the company compare on valuation and profitability?\">How does the company compare on valuation and profitability?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-caplin-point-laboratories-ltd-share-price-rise-today-2026\/#How_does_it_compare_with_major_pharma_peers\" title=\"How does it compare with major pharma peers?\">How does it compare with major pharma peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Caplin Point Laboratories Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,650.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,517.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 133.4 (+5.3%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,532.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,656.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,521.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,125.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Mid Cap<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,650.65 from the previous close of Rs 2,517.25, a move of Rs 133.4 or 5.3%. The stock opened at Rs 2,532.25, reached a high of Rs 2,656.85, recorded a low of Rs 2,521.4.<\/p>\n<p><strong>Caplin Point Laboratories Share Price<\/strong> rose from Rs 2,517.25 to Rs 2,650.65, a gain of Rs 133.4 or 5.3%. The session range of Rs 2,521.4 to Rs 2,656.85 shows the stock spent the day in positive territory after opening at Rs 2,532.25. Because the current price remained close to the intraday high, the session reflected firm buying interest rather than a move that faded sharply into the close snapshot supplied here.<\/p>\n<p>The market capitalisation stood at Rs 19,125.3 crore. The earlier article classified this as Mid Cap, and that size context matters because it places the company well above the broader same-industry median market capitalisation of Rs 683.05 crore and above the same-industry average of Rs 14,252.9 crore. Even without a confirmed event-specific reason, the combination of a 5.30% daily rise and a meaningful industry position is enough to place the stock on active watchlists.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Fundamental_Analysis\"><\/span><strong>Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,125.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 87.53<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 495.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.16%<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P\/E 28.76x, P\/B 5.08x, ROE 21.72%, ROCE 26.22%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Caplin Point Laboratories Ltd. has a market capitalisation of Rs 19125.3 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 28.76x, P\/B at 5.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.72% and ROCE of 26.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 495.39, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.87x to 667.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 19,125.3 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 683.05 crore<\/td>\n<\/tr>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P\/E ratio of 28.76x, which is below the benchmark median of 30.92x, a difference of -6.99%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 21.72%, which is above the benchmark median of 11.81%, a difference of +83.91%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 26.22%, which is above the benchmark median of 13.65%, a difference of +92.09%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,60,696.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,46,062.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,91,515.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,18,403.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,14,554.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P\/E ratio of 28.76x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.72% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 19,125.3 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Caplin_Point_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Caplin Point Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock rose 5.30% to Rs 2,650.65 and stayed near the day high of Rs 2,656.85.<\/li>\n<li>Turnover was Rs 1.83 crore, with price action ranging from Rs 2,521.4 to Rs 2,656.85.<\/li>\n<li>P\/E of 28.76x is below the same-industry median of 30.92x.<\/li>\n<li>ROE of 21.72% and ROCE of 26.22% are well above industry medians of 11.81% and 13.65%.<\/li>\n<li>The supplied data confirms a price rise, but not a company-specific catalyst.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Caplin_Point_Laboratories_Ltd\"><\/span><strong>About Caplin Point Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Caplin Point Laboratories Ltd. operates in Healthcare and is classified under Pharmaceuticals &amp; Drugs. Based on the supplied comparison set, it sits in an industry that includes very large listed peers such as Sun Pharma, Divi&#8217;s, Torrent, Zydus and Cipla. The stock therefore attracts interest not just for short-term movement, but also for how its valuation and returns stack up against better-known pharmaceutical businesses.<\/p>\n<p><strong>Caplin Point Laboratories Share Price<\/strong> is especially notable today because the company combines sub-industry-median P\/E with above-industry-median ROE and ROCE. That does not make the stock automatically attractive or unattractive, but it does explain why the name stands out in a same-day scan of price movers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Caplin_Point_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Caplin Point Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/caplipoint\/caplin-point-laboratories-ltd-share-price-today\">Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Readers can track <strong>Caplin Point Laboratories Share Price<\/strong> on the Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page. Univest users can also explore the top gainers screener and market blogs for broader market context, peer checks and daily stock analysis.<\/p>\n<p>For active tracking, investors typically watch live price changes, market capitalisation, valuation ratios, sector context and peer metrics in one place. That is especially useful after a session like today, when <strong>Caplin Point Laboratories Share Price<\/strong> moved sharply higher but the data set did not assign a confirmed trigger.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Caplin_Point_Laboratories_Share_Price_rising_today\"><\/span><strong>Why is Caplin Point Laboratories Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories Share Price rose 5.30% to Rs 2,650.65 from Rs 2,517.25, but the supplied data does not identify a company-specific catalyst behind the move. The previous close was Rs 2,517.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Caplin_Point_Laboratories_Share_Price_Today\"><\/span><strong>What is Caplin Point Laboratories Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Caplin Point Laboratories Share Price Today is Rs 2,650.65. The stock opened at Rs 2,532.25, hit Rs 2,656.85, touched Rs 2,521.40 and gained Rs 133.40 in the session. The previous close was Rs 2,517.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_company_compare_on_valuation_and_profitability\"><\/span><strong>How does the company compare on valuation and profitability?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company trades at P\/E 28.76x and P\/B 5.08x, with ROE 21.72%, ROCE 26.22%, EPS Rs 87.53, book value Rs 495.39 and dividend yield 0.16%. Versus the same-industry benchmark, P\/E is below the median 30.92x, while ROE and ROCE are.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_it_compare_with_major_pharma_peers\"><\/span><strong>How does it compare with major pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It has a smaller market cap than Sun Pharma, Divi&#39;s, Torrent, Zydus and Cipla, but its return ratios are competitive. ROCE of 26.22% is above all 5 displayed peers, while ROE of 21.72% is above Sun Pharma, Divi&#39;s, Zydus and.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Caplin Point Laboratories Ltd. Share Price rises to Rs 2,650.65. marking a 5.3% rise today. Market cap stands at Rs 19,125.3 crore.<\/p>\n","protected":false},"author":29,"featured_media":225446,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-225447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["225446"],"rank_math_title":["Caplin Point Laboratories Share Price Rises 5.30% Today"],"rank_math_description":["Caplin Point Laboratories Share Price gained 5.30% today. Check price action, market cap, valuation metrics and industry benchmark analysis."],"rank_math_focus_keyword":["Caplin Point Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Caplin_Point_Laboratories_Ltd_CAPLIPOINT_Caplin_Point_Laboratories_Share_Price_Rises_530_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=225447"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225447\/revisions"}],"predecessor-version":[{"id":225448,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225447\/revisions\/225448"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/225446"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=225447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=225447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=225447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}